Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
| Autor: | Tazza, F., Lapucci, C., Cellerino, M., Boffa, G., Novi, G., Poire, I., Mancuso, E., Bruschi, N., Sbragia, E., Laroni, A., Capello, E., Inglese, M. |
|---|---|
| Zdroj: | In Journal of the Neurological Sciences 15 August 2021 427 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect